Holen Sie sich die Stockscreener-App
159.84
0.49%
1.50
Schlusskurs vom Vortag:
$158.34
Offen:
$158.71
24-Stunden-Volumen:
108.69K
Relative Volume:
0.14
Marktkapitalisierung:
$12.33B
Einnahmen:
$8.27B
Nettoeinkommen (Verlust:
$173.28M
KGV:
73.62
EPS:
2.1712
Netto-Cashflow:
$785.90M
1W Leistung:
-0.45%
1M Leistung:
-3.28%
6M Leistung:
+44.62%
1J Leistung:
-5.81%
1-Tages-Spanne:
$157.25
$160.98
1-Wochen-Bereich:
$157.25
$165.91
52-Wochen-Spanne:
$66.57
$203.91
Icon Plc Stock (ICLR) Company Profile
Firmenname
Icon Plc
Sektor
Branche
Telefon
-
Adresse
-
Compare ICLR vs TMO, DHR, NTRA, IQV, IDXX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
159.77 | 12.22B | 8.27B | 173.28M | 785.90M | 2.1712 |
TMO
Thermo Fisher Scientific Inc
|
603.56 | 222.97B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.21 | 144.27B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
324.81 | 46.72B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
256.66 | 42.67B | 16.63B | 1.39B | 2.12B | 8.0674 |
IDXX
Idexx Laboratories Inc
|
518.88 | 40.98B | 4.45B | 1.10B | 1.06B | 13.59 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-26 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2026-02-23 | Hochstufung | Jefferies | Hold → Buy |
| 2026-02-18 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-02-17 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2026-02-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2026-02-12 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2026-01-08 | Herabstufung | Truist | Buy → Hold |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-09-09 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-03 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-07-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-21 | Herabstufung | Goldman | Buy → Neutral |
| 2025-01-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-10-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Neutral |
| 2024-09-18 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2023-12-15 | Eingeleitet | Truist | Buy |
| 2023-09-13 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-17 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-01-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-11-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-09-07 | Eingeleitet | UBS | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-09-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-14 | Eingeleitet | Citigroup | Neutral |
| 2021-04-13 | Fortgesetzt | BofA Securities | Neutral |
| 2021-04-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Equal Weight |
| 2021-03-01 | Hochstufung | UBS | Neutral → Buy |
| 2021-02-26 | Hochstufung | Truist | Hold → Buy |
| 2020-07-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-04-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Hold |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2018-10-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-09 | Eingeleitet | UBS | Sell |
| 2018-04-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-02-15 | Bestätigt | Mizuho | Neutral |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
| 2017-10-27 | Bestätigt | Barclays | Equal Weight |
| 2017-09-11 | Eingeleitet | BofA/Merrill | Buy |
| 2017-07-31 | Hochstufung | SunTrust | Hold → Buy |
| 2017-07-27 | Bestätigt | Mizuho | Neutral |
| 2017-06-29 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Icon Plc Aktie (ICLR) Neueste Nachrichten
Is Icon PLC (ICLR) a Bargain After 4.1% Drop? GF Value Says Unde - GuruFocus
CVS Health (CVS) Up 1% Since Last Earnings Report: Can It Continue? - Zacks Investment Research
Long term debt to total equity ratio of ICON Plc – HAM:IJF - TradingView
Icon plc stock holds steady as Q2 2026 results support full-year guidance - AD HOC NEWS
ICON Plc (ICLR) Stock Analysis: Exploring Growth Potential With A 9.14% Upside - DirectorsTalk Interviews
ICON plcADR Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
How ICON’s Mixed Q1 Earnings and Reaffirmed 2026 Outlook Could Impact ICON (ICLR) Investors - Sahm
Icon (ICLR) Stock Forecast and Price Target 2026 $ICLR - MarketBeat
ICON plc (ICLR) Stock Analysis: Navigating Growth in Diagnostics & Research with a 7.74% Upside - DirectorsTalk Interviews
ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation and Sustainability - BioSpace
ICON plc (ICLR) posts top-1% ESG score and 73% emissions cut - Stock Titan
A Look at Icon PLC (ICLR) After 3.2% Gain -- GF Value $208.22 vs Price $172.49 - GuruFocus
ETFs Investing in ICON Plc Stocks - TradingView
ICON plc (NASDAQ: ICLR) swaps secured loans for $2.15B in new notes - Stock Titan
White & Case advises ICON on its US$2.15 billion notes offering and related secured debt refinancing - White & Case LLP
6-K: Icon PLC | 6-K: Report of foreign private issuer (related to financial reporting) - Moomoo
Icon PLC (ICLR) Shares Surge 3.9% -- What GF Score of 93 Tells I - GuruFocus
ICON plc (ICLR) Stock Analysis: Strong Buy Ratings and 13.74% Potential Upside Highlight Investment Appeal - DirectorsTalk Interviews
Icon CEO awarded $3.7m in shares as company emerges from turmoil - Irish Independent
Does ICON’s Shift to an Unsecured Capital Structure Reshape the Bull Case for ICLR? - Sahm
Icon Plc $ICLR Shares Bought by Handelsbanken Fonder AB - MarketBeat
Invesco Ltd. (ICLR) discloses 6.9% beneficial stake in ICON PLC - Stock Titan
Director Of Icon Makes $138K Sale - Benzinga
ICON plc (ICLR) Rises 0.96% to $167.17 on Steady CRO Sector DemandInstitutional Buy Signals - vinanet.vn
Trinity Street Asset Management LLP Raises Stock Position in Icon Plc $ICLR - MarketBeat
ICON PLC (ICLR) director logs RSU vesting, new grant and tax sell-to-cover trades - Stock Titan
ICON plc (ICLR) director’s RSU vesting triggers tax-related share sales - Stock Titan
ICON PLC (ICLR) director sells 2,677 shares, receives new 2,047 RSU grant - Stock Titan
ICON PLC (ICLR) director sells 841 shares to cover RSU taxes, gets new grant - Stock Titan
ICON PLC (ICLR) director reports RSU vesting, new grant and tax sell-to-cover sales - Stock Titan
ICON PLC (ICLR) awards 5,886 restricted share units to Chief Accounting Officer - Stock Titan
ICON PLC (ICLR) director Linda Grais sells shares to cover taxes, gets new RSU grant - Stock Titan
ICON plc (ICLR) director Climax details RSU vesting, new grant and tax sell-to-cover trades - Stock Titan
ICON plc (ICLR) CFO gets new RSUs, options and sells shares for taxes - Stock Titan
ICON PLC (ICLR) awards 1,324 Restricted Share Units to director Kevin Francis Egan - Stock Titan
Edward Barry Balfe Decides To Exercise Options At Icon Worth $0 - benzinga.com
FMR LLC Buys Icon PLC (ICLR) -- Shares Look 21% Undervalued on G - GuruFocus
ICON plc (ICLR) investor files to sell 915 restricted shares under Rule 144 - Stock Titan
ICON plc (NASDAQ: ICLR) holder plans $138K sale of vested shares - Stock Titan
ICLR (ICLR) shareholder files to sell 841 vested shares on NASDAQ - Stock Titan
ICON plc (NASDAQ: ICLR) holder files Form 144 to sell 841 shares - Stock Titan
ICLR shareholder plans sale of 841 common shares | ICLR SEC FilingForm 144 - Stock Titan
ICON plc (ICLR) holder files notice to sell 841 vested shares on NASDAQ - Stock Titan
Icon plc (NASDAQ: ICLR) plans sale of 2,267 vested restricted shares - Stock Titan
ICON plc (ICLR) files Form 144 for sale of 2,677 vested shares on NASDAQ - Stock Titan
ICON PLC (ICLR) grants 1,324 Restricted Share Units to director Elliott - Stock Titan
ICON PLC (ICLR) awards RSUs, options to CEO Balfe and sells shares to cover tax - Stock Titan
Bank of America Corp DE Has $60.14 Million Stock Holdings in Icon Plc $ICLR - MarketBeat
ICLR (ICLR) insider files Form 144 to sell 382 vested shares - Stock Titan
Polianta Ltd Acquires New Stake in Icon Plc $ICLR - MarketBeat
ICON PLC (ICLR) Stock News Today - TradingKey
Finanzdaten der Icon Plc-Aktie (ICLR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Icon Plc-Aktie (ICLR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| O'Neill Julie | Director |
Aug 11 '26 |
Sale |
164.29 |
915 |
150,326 |
3,515 |
| Murray Ciaran | Director |
Aug 11 '26 |
Sale |
164.29 |
2,677 |
439,803 |
20,452 |
| Murphy Ronan Martin | Director |
Aug 11 '26 |
Sale |
164.29 |
841 |
138,168 |
3,847 |
| McCague Eugene Pacelli | Director |
Aug 11 '26 |
Sale |
164.29 |
841 |
138,168 |
3,811 |
| Grais Linda | Director |
Aug 11 '26 |
Sale |
164.29 |
841 |
138,169 |
6,162 |
| CLIMAX JOHN DR | Director |
Aug 11 '26 |
Sale |
164.29 |
841 |
138,168 |
2,087 |
| Clerkin Nigel Bernard John | Chief Financial Officer |
Aug 11 '26 |
Sale |
164.29 |
2,267 |
372,445 |
5,881 |
1.07%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):